Daniel Brennan

Board Member

Equibles does not estimate personal net worth.

About Daniel Brennan

Daniel Brennan is recorded as Board Member at Vertex Pharmaceuticals Inc (VRTX) since October 20, 2026. Vertex Pharmaceuticals Inc reported in an 8-K filed October 20, 2026 that Daniel Brennan was appointed new member of the board of directors, effective October 20, 2026. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.

“On October 20, 2026, Daniel Brennan was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”).”

Vertex Pharmaceuticals Inc Form 8-K, filed October 20, 2026 · Read the filing

Affiliation history

Vertex Pharmaceuticals Inc (VRTX)
Board Member

SEC 8-K

Current
2026-10-20–present

Company network

Vertex Pharmaceuticals Inc

VRTX

Current role

Biotechnology · Healthcare

Board Member

2026-10-20–present

Leadership on record at Vertex Pharmaceuticals Inc

Dr. Reshma Kewalramani CEO
Reshma Kewalramani CEO, Board Member
Dr. Jeffrey M. Leiden Chairman
Jeffrey Leiden Chairman, Board Member
Charles Wagner CFO
Jonathan Poole CFO
Charles F. Wagner, Jr. COO
Alan Garber Board Member
Bruce Sachs Board Member
Diana McKenzie Board Member

Recent activity

Executive change Appointed: new member of the board of directors Vertex Pharmaceuticals Inc (VRTX)
2026-10-20